Clinical Trial Update: Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy [NA]

View source ↗

Summary

Clinical trial evaluating skin barrier dysfunction in infants at high risk of atopy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Food Allergy

Snippet

Sponsor: National Jewish Health | Conditions: Atopic Dermatitis, Eczema | NA | Status: WITHDRAWN